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A crotonyl-CoA reductase-carboxylase
independent pathway for assembly of unusual
alkylmalonyl-CoA polyketide synthase extender
units
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Type I modular polyketide synthases assemble diverse bioactive natural products. Such
multienzymes typically use malonyl and methylmalonyl-CoA building blocks for polyketide
chain assembly. However, in several cases more exotic alkylmalonyl-CoA extender units are
also known to be incorporated. In all examples studied to date, such unusual extender units
are biosynthesized via reductive carboxylation of a, b-unsaturated thioesters catalysed by
crotonyl-CoA reductase/carboxylase (CCRC) homologues. Here we show using a chemically-
synthesized deuterium-labelled mechanistic probe, and heterologous gene expression
experiments that the unusual alkylmalonyl-CoA extender units incorporated into the stam-
bomycin family of polyketide antibiotics are assembled by direct carboxylation of medium
chain acyl-CoA thioesters. X-ray crystal structures of the unusual b-subunit of the acyl-CoA
carboxylase (YCC) responsible for this reaction, alone and in complex with hexanoyl-CoA,
reveal the molecular basis for substrate recognition, inspiring the development of
methodology for polyketide bio-orthogonal tagging via incorporation of 6-azidohexanoic acid
and 8-nonynoic acid into novel stambomycin analogues.
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M
odular polyketide synthases (PKSs) are bacterial
molecular machines responsible for the assembly of
numerous structurally-complex bioactive natural
products with diverse applications in medicine and agricul-
ture1. Important examples of modular PKS products include:
erythromycin, rifamycin and ﬁdaxomicin (antibacterials);
amphotericin and nystatin (antifungals); rapamycin and FK-506
(immunosuppressants); spinosyns (insecticides) and avermectins
(insecticides and anthelmintics). These remarkable multienzymes
employ various tactics to generate structural diversity, such as
variation in the number of modules within the assembly line, and
of the a and b-carbon-modifying domains within each module; in
trans recruitment of a range of enzymes that modify the growing
polyketide during chain assembly; utilization of several distinct
mechanisms for termination of chain assembly, and a wide
variety of starter and extender units1.
The stambomycins 1–4 (Fig. 1a) are a novel class of macrolide
antibiotics recently identiﬁed as products of a modular PKS via a
rational activation of a silent biosynthetic gene cluster in
Streptomyces ambofaciens ATCC23877 (refs 2,3). The majority
of the stambomycin PKS chain elongation modules are predicted
to employ widely-used malonyl and (2S)-methylmalonyl-
CoA extender units (Fig. 1)2. The exception is module 12,
which is postulated to incorporate several atypical pentyl- and
hexylmalonyl-CoA-based extender units, giving rise to the
structural variants of the stambomycin complex (Fig. 1)2.
Several unusual extender units are known to be utilized by
other modular PKSs, including those responsible for the assembly
of salinosporamide A (chloroethylmalonyl-CoA) (ref. 4),
cinnabaramide A (n-hexylmalonyl-CoA) (ref. 5), ﬁlipin III
(n-hexylmalonyl-CoA) (ref. 6), antimycins (n-butylmalonyl-
CoA, n-hexylmalony-CoA) (ref. 7), splenocins (benzylmalonyl-
CoA) (ref. 8), FK-506 (allylmalonyl-CoA) (ref. 9), chlorizidines
(dichloropyrrolyl-propylmalonyl-ACP) (ref. 10), and the
reveromycins (n-butylmalonyl-CoA, iso-butylmalonyl-CoA,
n-pentylmalonyl-CoA and n-hexylmalonyl-CoA) (ref. 11). In all
of these examples, the ﬁnal step of unusual extender unit
biosynthesis is catalysed by a homologue of crotonyl-CoA
reductase/carboxylase (CCRC) and involves NADPH-mediated
reduction of an a, b-unsaturated thioester, followed by trapping
of the resulting enolate by reaction with carbon dioxide12–14. The
genes encoding such CCRC homologues are invariably clustered
with the genes encoding the polyketide synthases they supply4–11.
Remarkably, no genes encoding CCRC homologues can be found
in the stambomycin biosynthetic gene cluster (BGC) (ref. 2),
suggesting that the unusual extender units incorporated into the
stambomycins may be assembled by a CCRC-independent
mechanism.
Acyl-CoA carboxylases (YCCs) generate the malonyl and
methylmalonyl-CoA extender units commonly utilized by
modular PKSs, in addition to carrying out a variety of other
carboxylation reactions15. YCCs consist of three components:
a biotin carboxylase (BC), a biotin carboxyl carrier protein
(BCCP) and a carboxyl transferase (CT)15. The distrubtion of
these components between protein subunits differs depending on
the organism and the nature of the substrate15. In Streptomyces
species the YCCs acetyl-CoA carboxylase (ACC) and propionyl-
CoA carboxylase (PCC) assemble malonyl and methylmalonyl-
CoA via carboxylation of acetyl- and propionyl-CoA,
respectively16,17. ACC and PCC consist of a common
a-subunit, AccA2 and dedicated b-subunits, AccB and PccB,
respectively. AccA2 contains an N-terminal BC domain and a
C-terminal BCCP domain and AccB/PccB contain CT domains
with preference for acetyl-CoA/propionyl-CoA as substrates. In
addition, a non-catalytic e-subunit has been reported to enhance
the catalytic activity of ACC and PCC in vitro16. The samR0483
gene within the stambomycin biosynthetic gene cluster encodes a
protein with 72% similarity to PccB from S. coelicolor. In
partnership with AccA2, the putative YCC b-subunit encoded by
samR0483 has been proposed to be responsible for assembly of
the unusual extender units incorporated into the stambomycins
(Fig. 1)2. However, the biosynthesis of unusual PKS extender
units by YCCs is without precedent. Moreover, the S. ambofaciens
genome contains several genes encoding homologues of CCRCs,
albeit not clustered with the stambomycin biosynthetic genes and
predicted on the basis of sequence alignments to be incapable of
directing the production of pentyl- or hexylmalonyl-CoAs
(Supplementary Fig. 1). Thus, the biosynthetic mechanism for
the unusual extender units incorporated into the stambomycins
is unclear.
Here we report a series of experiments that elucidate the
biosynthetic origin and mechanism of assembly of the unusual
stambomycin PKS extender units. Incorporation of stable
isotope-labelled precursors indicate that they originate from fatty
acid metabolism. Retention of both deuterium atoms in the
stambomycin analogue derived from feeding of [3-2H2]heptanoic
acid to S. ambofaciens rules out the involvement of a CCRC in
unusual extender unit biosynthesis. Direct evidence for the
involvement of samR0483 in this process is provided by
expression of this gene in a revT mutant of Streptomyces
sp. SN-593, in which the CCRC-dependent pathway for the
biosynthesis of n-pentylmalonyl-CoA (and related) extender units
incorporated into the reveromycins is abolished. X-ray crystal
structures of SamR0483 alone and in complex with hexanoyl-
CoA reveal the molecular basis for medium chain acyl-CoA
recognition by this unusual YCC b-subunit, prompting us to
rename it medium chain acyl-CoA carboxylase beta subunit
(MccB). Taken together, these results establish the existence of a
unique YCC-dependent pathway for unusual polyketide extender
unit biosynthesis. Finally, the potential of this pathway to be
harnessed for selective polyketide derivatization is demonstrated
by feeding 6-azidohexanoic acid and 8-nonynoic acid to S.
ambofaciens, resulting in production of the corresponding azide
and alkyne-tagged stambomycin analogues.
Results
Metabolic origin of the C-26 side chains of the stambomycins.
Stambomycins A-D 1–4 differ in the length and methylation
pattern of their C-26 side chains2, which are of unknown
biosynthetic origin. In Streptomyces species, the FabH component
of the core metabolic fatty acid synthase (FAS) catalyses
elongation of 2-methylbutyryl-, 3-methylbutyryl-, iso-butyryl-,
and n-butyryl-CoA (5-8) starter units with malonyl-ACP18.
Subsequent rounds of chain elongation are catalysed by FabF19.
2-Methylbutyryl-CoA (5), 3-methylbutyryl-CoA (6) and
iso-butyryl-CoA (7) derive from transamination and oxidative
decarboxylation of L-isoleucine, L-leucine and L-valine
respectively (Fig. 2)19. We hypothesized that the C-26 side
chains of the stambomycins are derived from 5-8. To test this
hypothesis, we fed universally deuterium labelled L-isoleucine (9),
L-leucine (10), L-valine (11) and n-butyric acid (12) separately to
cultures of S. ambofaciens W130 (a mutant of the ATCC23877
strain with an extra copy of samR0484, which encodes a pathway-
speciﬁc transcriptional regulator of the stambomycin BGC,
integrated into its chromosome under the control of the
constitutive ermE* promoter). LC-ESI-TOF-MS analyses of
mycelial extracts from these experiments showed that L-
isoleucine and L-leucine are speciﬁcally incorporated into
stambomyins A and B, whereas L-valine and n-butyric acid
are speciﬁcally incorporated into stambomycins C and D,
respectively (Fig. 2 and Supplementary Figs 2–5). These data
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are consistent with biosynthesis of the (4-methylhexyl),
(5-methylhexyl), (4-methylpentyl) and n-hexylmalonyl-CoA
extender units (17–20) incorporated into stambomycins A-D,
respectively, from the corresponding fatty acids, that is
6-methyloctanoic acid (13), 7-methyloctanoic acid (14),
6-methylheptanoic acid (15) and n-octanoic acid (16) (Fig. 2).
These fatty acids are probably converted to their CoA thioesters
by SamR0482, a homologue of the medium chain fatty acyl-
CoA ligase RevS, which was recently shown to participate
in the biosynthesis of unusual extender units for the reveromycin
PKS11.
A mechanistic probe for unusual extender unit biosynthesis.
Feeding of heptanoic acid (21) to S. ambofaciens W130 resulted
in the production of a novel stambomycin derivative 22 with an
n-pentyl side chain at C-26 (Fig. 3; Supplementary Figs 6–11),
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Figure 1 | The stambomycin structures, their biosynthetic gene cluster in S. ambofaciens ATCC23877 and the modular PKS it encodes. (a) Structures of
stambomycin A-D. The major constituents of the complex, stambomycins A-D (1-4), differ in the nature of their C-26 side chains. (b) Organization of the
stambomycin biosynthetic gene cluster, highlighting the location of the samR0483 gene encoding an acyl-CoA carboxylase b-subunit proposed to be
involved in unusual extender unit biosynthesis. (c) Module and domain organization of the stambomycin PKS and structure of the polyketide chain it
assembles. Carbon atoms derived from malonyl-CoA extender units are highlighted in red, while those derived from a methylmalonyl-CoA starter unit and
methylmalonyl-CoA extender units are highlighted in purple. The carbon atoms derived from the unusual extender units utilized by PKS module 12 (boxed)
are highlighted in blue (R1, R2 and R3¼Me or H, depending on which of the unusual extender units is incorporated in a particular round of chain assembly).
The acyltransferase (AT) domains responsible for loading of each of these building blocks onto the adjacent acyl carrier protein (ACP) domains are colour-
coded accordingly.
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providing further support for the proposed fatty acid origin of
the unusual extender units and highlighting the ability of the
acyltransferase (AT) domain within module 12 of the stambo-
mycin PKS to tolerate unnatural substrates. This inspired us to
synthesize [3-2H2]heptanoic acid (23) as a mechanistic probe to
determine whether the unusual extender units incorporated
into the stambomycins are assembled by a CCRC or YCC-
dependent pathway. Incorporation of [3-2H2]heptanoic acid
(23) into the stambomycin analogue (22) via a CCRC-depen-
dent pathway would be expected to proceed via initial
SamR0482-catalysed conversion to the CoA thioester (24),
followed by b-oxidation to yield the corresponding a, b-unsa-
turated thioester (25) and reductive carboxylation to yield
n-pentylmalonyl-CoA (26) containing only a single deuterium
label (Fig. 3). In contrast, the YCC-dependent pathway would
proceed via direct carboxylation of [3-2H2]heptanoyl-CoA (24),
resulting in n-pentylmalonyl-CoA (26) containing two
deuterium labels (Fig. 3). Thus, both of the deuterium atoms
would be expected to be retained in the stambomycin analogue
if n-pentylmalonyl-CoA is biosynthesized via the YCC-depen-
dent pathway, whereas one of the deuterium labels would be
lost if this extender unit is assembled by the CCRC-dependent
pathway.
[3-2H2]heptanoic acid 23 was synthesized in ﬁve steps from
methyl-n-pentanoate 27 (Fig. 3; Supplementary Figs 12 and 13).
Reduction of methyl-n-pentanoate 27 with LiAlD4 yielded
[1-2H2]pentanol 28, which was converted to its tosylate derivative
29 by reaction with TsCl, DMAP and Et3N. Deprotonation of
dimethyl malonate with sodium hydride followed by alkylation
with 29 gave 30. Hydrolysis of 30 with sodium hydroxide
in methanol afforded the corresponding diacid 31, which was
decarboxylated by reﬂuxing in toluene to give yield the mecha-
nistic probe 23.
Comparison of the mass spectra for stambomycin analogue 22
from LC–ESI–TOF–MS analyses of mycelial extracts of
S. ambofaciens W130 cultures that had been fed with labelled
and unlabelled heptanoic acid showed that the [Mþ 2H]2þ
parent ions differ by one m/z unit (Fig. 3). Thus both atoms of
deuterium are retained when [3-2H2]heptanoic acid 23 is
incorporated into stambomycin analogue 22, because the parent
ion is doubly charged (Fig. 3; Supplementary Fig. 14). These
results conﬁrmed that the pentylmalonyl-CoA extender unit
incorporated into stambomycin analogue 22 is biosynthesized via
an YCC-dependent pathway.
To further demonstrate the ability of our mechanistic probe to
distinguish between CCRC and YCC-dependent pathways for
unusual polyketide extender unit biosynthesis, we investigated the
incorporation of [3-2H2]heptanoic acid 23 into revermomycin D
32. Streptomyces sp. SN-593 produces reveromycins A, C, D and
E (33, 34, 32 and 35), a family of structurally-related polyketides
that differ in the nature of their C-18 side chains (Fig. 4)20. The
structural differences between the reveromycins result from the
utilization of various unusual extender units by module 4 of the
reveromycin polyketide synthase20. The revR, revS and revT
genes, which encode a FabH homologue, a medium chain fatty
acyl-CoA ligase, and a CCRC, respectively, have recently been
implicated in the biosynthesis of these extender units11.
Reveromycin D 32 incorporates n-pentylmalonyl-CoA, but its
abundance is low relative to reveromycin A 33, which is derived
from an n-butylmalonyl-CoA extender unit. Deletion of revR
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Figure 2 | Incorporation of precursors of FAS starter units into the C-26 side chains of the stambomycins. (a) Incorporation of [U-2H]L-isoleucine 9 into
the FAS starter unit 2-methylbutyryl-CoA 5, the fatty acid 6-methyloctanoic acid 13, the extender unit (4-methylhexyl)malonyl-CoA 17, and stambomycin
A 1. (b) Incorporation of [U-2H]L-leucine 10 into the FAS starter unit 3-methylbutyryl-CoA 6, the fatty acid 7-methyloctanoic acid 14, the extender unit
(5-methylhexyl)malonyl-CoA 18, and stambomycin B 2. (c) Incorporation of [U-2H]L-valine 11 into the FAS starter unit iso-butyryl-CoA 7, the fatty acid
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suppresses the production of reveromycin A 33 relative to the
other congeners11. Thus, we fed [3-2H2]heptanoic acid 23 to a
revR mutant of Streptomyces sp. SN-593. LC–MS analysis of an
ethyl acetate extract of this culture showed that [3-2H2]heptanoic
acid 23 was incorporated into reveromycin D 32 with retention of
only a single deuterium label, consistent with the assembly of
n-pentylmalonyl-CoA in Streptomyces sp. SN-593 via a CCRC-
dependent pathway (Fig. 4)11. Moreover, high resolution ESI-MS
analysis of partially puriﬁed reveromycins A, C and D conﬁrmed
that [3-2H2]heptanoic acid 23 is incorporated exclusively into
reveromycin D 32 (Supplementary Fig. 15).
Functional equivalence of SamR0483 and the CCRC RevT.
In-frame deletion of revT in Streptomyces sp. SN-593 has been
recently reported to abolish reveromycin production11.
Expression of samR0483 in the revT mutant restored the
production of reveromycin E 35 (Fig. 4), demonstrating the
ability of the YCC b-subunit encoded by this gene to
biosynthesize n-hexylmalonyl-CoA. Only trace amounts of
reveromycins A and D were observed in the revT mutant
expressing samR0483. However, feeding of [3-2H2]heptanoic acid
23 to this strain resulted in production of a modest amount of
reveromycin D 32 in which both of the deuterium labels were
retained (Supplementary Fig. 16). This is consistent with
assembly of the n-pentylmalonyl-CoA extender unit incorpo-
rated into reveromycin D 32 via an YCC-dependent pathway in
the revT::samR0483 mutant.
X-ray crystal structure SamR0483. To develop a better under-
standing of the molecular basis for the unique substrate speciﬁcity
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of the acyl-CoA carboxylase b-subunit encoded by samR0483,
hereafter referred to as MccB, we solved its crystal structure to
2.45Å. MccB was crystallized as a hexamer in the orthorhombic
P212121 space group, and was solved via molecular replacement
using the hexameric PccB D422A mutant structure (PDB ID:
3IBB) as a search model. Similar to other bacterial YCC b-sub-
units, MccB has 3–2 symmetry and is composed of three indi-
vidual dimers that form a ring-like hexamer (Fig. 5). Each
monomer can be divided into two domains harbouring two
copies of the crotonase fold that pack together in an antiparallel
manner to form a dimer (Fig. 5). The active site of MccB is
located at the dimerization interface for two opposing monomers
where residues 137–237 from the N-terminus of monomer B
are packed against residues 392–492 from the C-terminus of the
next proximal monomer F (Fig. 5). The individual monomers
themselves superimpose well with a backbone Ca RMSD of
0.167Å.
Overall, MccB has a high degree of structural similarity to the
previously solved b-subunit of propionyl-CoA carboxylase PccB
from Streptomyces coelicolor21, with a Ca backbone RMSD of
0.738 Å (Supplementary Fig. 17). Consequently, the vast
majority of the known substrate and cofactor binding residues
of YCC b-subunits are both structurally and sequentially
conserved for MccB, PccB and AccD5 from Mycobacterium
tuberculosis (Supplementary Fig. 18)21,22. The greatest structural
deviations of MccB from previously solved structures occur near
residues 33–46 and 452–477. Residues 33–46 of MccB form a
long a-helix resulting in a larger cavity near the substrate
binding zone. Residues 452–477 of MccB could not be modelled
in the apo structure, highlighting this region’s high degree of
ﬂexibility. In contrast, the region corresponding to residues
452–477 for PccB adopts a partially ordered helix–loop–helix
motif. The high ﬂexibility of MccB in the vicinity of the
substrate binding pocket is consistent with its ability to bind
larger acyl-CoA substrates than PccB.
Molecular basis for hexanoyl-CoA recognition. Given the high
degree of structural and sequence similarity between MccB and
PccB, it was not immediately clear how the former is able to
accommodate signiﬁcantly longer acyl-CoA substrates than the
latter. To address this question structures of MccB bound to
either one or four molecules of hexanoyl-CoA were solved to 2.75
and 2.85Å, respectively (Fig. 5; Supplementary Fig. 19). These
co-crystal structures were obtained via incubation of MccB with 5
or 10mM hexanoyl-CoA before crystallization. Interestingly, the
electron density corresponding to residues 452–477 of monomer
F was only present in the crystal form bound to four molecules of
hexanoyl-CoA, suggesting that the helix-loop-helix lid region of
MccB is stabilized at higher substrate concentrations.
The hexanoyl-CoA bound structures reveal that some of the
substrate-binding features of MccB are similar to those employed
by other YCC b-subunits. For example, the residues that interact
with the adenine ring of the substrate are conserved between
MccB and PccB. However, MccB and PccB recognize the
phosphopantetheine (PPant) and acyl moieties of hexanoyl-
CoA quite differently (see below).
The residues that interact with hexanoyl-CoA are localized in
three regions at the MccB dimer interface. The ﬁrst region is
located at the entrance of the substrate binding pocket, which is
characterized by a network of hydrogen bonds between the
adenosine moiety of hexanoyl-CoA and the protein. The
exocyclic amine and N-1 of adenine form hydrogen bond
contacts with the peptide backbone of Ile147, Ala145 and Gly143
monomer B (Fig. 5). The adenosine moiety is further stabilized by
a hydrogen bond from the backbone carbonyl group of Pro453 to
the 2’ hydroxyl group of ribose (Fig. 5). The second region is the
PPant binding site, in which the backbone N-H groups of Ala145
and Gly184 in monomer B form hydrogen bonds to the carbonyl
oxygen atom of the b-alanine component of PPant. In addition,
the sulfur atom of the thioester is hydrogen bonded to the
backbone N-H of Gly420 (Fig. 5). The third region is the binding
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Figure 4 | Reveromycins produced by Streptomyces sp. SN-593 wild type and revT::samR0483 mutant. (a) Structures of the reveromycins produced by
wild type Streptomyces sp. SN-593. The site of unusual alkylmalonyl-CoA extender unit incorporation is highlighted in-red. (b, c) Mass spectra of
reveromycin D (32) from UHPLC-ESI-MS analyses of ethyl acetate extracts of Streptomyces sp. SN-593 revR mutant cultures grown in the absence (b) and
presence (c) of (3-2H2)heptanoic acid (23). The increase in intensity of the m/z¼674 peak in the right spectrum is consistent with incorporation of
(3-2H2)heptanoic acid (23) into reveromycin D (32) with loss of one of the two deuterium labels. (d, e, f) Extracted ion chromatograms at m/z¼ 687–688
corresponding to [M-H] for reveromycin E from UHPLC-ESI-MS analyses of ethyl acetate extracts of wild type Streptomyces sp. SN-593 (d), the revT
mutant (e) and the revTmutant (f) in which samR0483 has been expressed.
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pocket for the aliphatic portion of the substrate, which is formed
primarily by the hydrophobic side chains of Ile396, Phe399 and
Ala423 in Monomer F, and Leu191, Tyr157 and Tyr187 in mono-
mer B (Fig. 5). Collectively, these three sets of interactions serve
to anchor hexanoyl-CoA strongly into the active site of MccB.
The structures of MccB with hexanoyl-CoA bound were
compared with the previously-reported structure of PccB bound
to propionyl-CoA (Fig. 5)21. In the PccB co-crystal structure,
propionyl-CoA binds close to the entrance of the active site,
leaving the 3’ phosphate of CoA more exposed to the solvent. In
contrast, MccB sequesters its substrate deep into the active site via
hydrophobic interactions between the side chains of the residues
lining the substrate binding pocket and the aliphatic portion of
hexanoyl-CoA. Further, the adenine ring of hexanoyl-CoA is
tiltedB90 with respect to that of the adenine-ring of propionyl-
CoA in the PccB co-crystal structure. Residue 421 of PccB is Asp,
whereas in MccB the corresponding residue is Ala. Mutation of
Asp421 to Ala allows PccB to bind substrates with a longer
aliphatic chain, such as butyryl-CoA23. This suggests that the
negatively-charged Asp421 side chain of PccB diminishes the
hydrophobic character of the binding pocket, thus biasing its
substrate speciﬁcity towards acyl-CoAs with shorter aliphatic
chains. In comparison, the MccB substrate binding pocket
consists of more hydrophobic residues, with higher ﬂexibility at
the substrate entrance thus allowing it to accommodate longer
aliphatic chains.
Further insight into the molecular basis for the unique
substrate speciﬁcity of MccB was gleaned from sequence align-
ments and detailed structural comparisons with other YCC
b-subunits (Fig. 5 and Supplementary Fig. 20). Structural
alignment of MccB with PccB demonstrated that Gly161 in the
former corresponds to a bulky Phe residue in the latter.
Superimposition of the substrate bound MccB and PccB
structures strongly suggested that replacing Gly161 with Phe in
MccB would cause a steric clash with the aliphatic chain of
hexanoyl-CoA (Fig. 5). Indeed, sequence alignments reveal that
Phe is universally conserved in position 161 of all YCC
b-subunits known to carboxylate acyl-CoAs with four carbons
or less (Supplementary Fig. 20).
Precursor-directed biosynthesis of stambomycin analogues.
Inspired by the insights into the molecular basis for substrate
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Figure 5 | X-ray crystal structures of apo-MccB and holo-MccB. (a) The hexameric overall structure of apo-MccB. (b) The substrate binding site at the
subunit interface of apo-MccB. (c) Structure of MccB with 4 molecules of hexanoyl-CoA bound, showing the overall architecture of the complex with
hexanoyl-CoA in space ﬁlling representation. (d) Polar contacts between hexanoyl-CoA and MccB. Residues labelled in black correspond to monomer F and
residues labelled in grey correspond to monomer B of the MccB homo-dimer. (e) Residues lining the hydrophobic pocket in MccB that bind the aliphatic
chain of hexanoyl-CoA. (f) Overlay of the structures of MccB (green) and PccB (cyan), highlighting residues lining the binding pockets for the aliphatic
chains of hexanoyl- and propionyl-CoA, their respective substrates.
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speciﬁcity generated by our structural analysis of MccB, we
sought to further probe the enzyme’s substrate tolerance by
investigating the precursor-directed biosynthesis of additional
stambomycin analogues. In particular, we targeted the production
of analogues bearing an alkyne or azide group at the terminus of
the C-26 substituent, with the aim of carrying out click chemistry
on these functional groups to produce biotinylated or ﬂuores-
cently-labelled stambomycin derivatives for future mechanism of
action studies.
Thus, we fed commercially available 6-azidohexanoic acid 36
to cultures of S. ambofaciens W130. UHPLC-ESI-TOF-MS
analyses of mycelial extracts identiﬁed a novel metabolite
with the molecular formula C70H128N4O22 (calculated for
[C70H129N4NaO22]2þ : 699.4414; found: 699.4419), correspond-
ing to the stambomycin analogue 37 (Fig. 6; Supplementary
Fig. 21). This analogue presumably arises from the conversion of
6-azidohexanoic acid 36 to its CoA thioester followed by MccB-
mediated carboxylation to produce 4-azidobutylmalonyl-CoA,
which is then utilized as an extender unit by module 12 of the
stambomycin PKS. However, the production level of stambomy-
cin analogue 37 is relatively modest compared with that of
stambomycins A-D 1-4 (Supplementary Fig. 21), suggesting that
azide-containing substrates are not well tolerated by SamR0482,
MccB or stambomycin PKS module 12. Indeed, we were not able
to obtain sufﬁcient quantities of 37 for NMR spectroscopic
analysis.
Surprisingly, feeding of commercially available 6-heptynoic
acid 38 to S. ambofaciens W130 resulted in the production
of a new metabolite with the molecular formula C73H129NO22
(calculated for [C73H130NNaO22]2þ : 697.9486; found: 697.9505),
corresponding to the stambomycin analogue 39 derived from
8-nonynoic acid (Fig. 6; Supplementary Fig. 22). This analogue
presumably arises from 2-carbon elongation of 6-heptynoic acid
38 by the primary metabolic FAS of S. ambofaciens, yielding
8-nonynoic acid 40, which is converted to its CoA thioester,
carboxylated by MccB, and utilized as an extender unit by module
12 of the stambomycin PKS. To test this hypothesis, we
synthesized 8-nonynoic acid 40 and fed it to S. ambofaciens
W130. This resulted in the production of stambomycin analogue
39 at a similar level to that of stambomycins A and B combined
(Fig. 6; Supplementary Fig. 23), allowing sufﬁcient quantities
of the analogue to be puriﬁed for 1H NMR spectroscopic
analysis (Supplementary Fig. 24). The reaction of 39 with
commercially available azide-PEG3-biotin resulted in conversion
to the corresponding biotinylated compound (Supplementary
Fig. 25), providing proof of principle for the production of
bio-orthogonally-tagged stambomycin derivatives.
YCCs assemble other unusual PKS extender units. BLAST
searches identiﬁed two other polyketide biosynthetic gene clusters
that contain genes encoding an YCC b-subunit with the same
speciﬁcity-conferring residues as S. ambofaciens MccB (Supple-
mentary Fig. 20). These clusters also contain genes encoding
homologues of SamR0482. One of these genes clusters has
recently been reported to direct the biosynthesis of the primycin
complex of antibiotics24, which has been used in the clinic as a
topical antibiotic and has recently been shown to be effective
against multi-drug resistant Gram-positive pathogens, including
methicillin- and mupirocin-resistant Staphylococcus aureus25.
Butylmalonyl-CoA is incorporated into primycin A1 (41)
(Fig. 7), and other members of the primycin complex appear to
derive from similar 6, 7 and 8-carbon alkylmalonyl-CoA extender
units24. It seems highly likely that these extender units are
assembled by the sequential action of the SamR0482 and MccB
homologues in the primycin producer.
The other gene cluster encoding MccB and SamR0482
homologues is cryptic (that is its metabolic product is unknown).
It encodes only a single PKS module, and is widely conserved in
Amycolatopsis species. The results presented herein suggest that it
might be possible to produce an acetylene-tagged derivative of the
metabolic product of this gene cluster which may facilitate
puriﬁcation and subsequent identiﬁcation via a click-mediated
biotinylation and avidin afﬁnity puriﬁcation strategy.
Discussion
Several examples of unusual type I modular PKS extender units
have been reported over the past half-decade. In all cases, these
are assembled via a common ﬁnal biosynthetic step, involving
reductive carboxylation of an a, b-unsaturated CoA thioester by a
CCRC homologue. The data reported here reveal an alternative
mechanism for assembly of unusual type I modular PKS extender
units. This employs a unique YCC b-subunit (MccB) that, in
partnership with the primary metabolic YCC a-subunit, is able to
directly carboxylate medium chain acyl-CoA thioesters. X-ray
crystallographic analysis revealed the structural basis for substrate
recognition by MccB, allowing a homologue likely involved in the
biosynthesis of butylmalonyl-CoA and other unusual extender
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Figure 6 | Bio-orthogonally-tagged stambomycin analogues produced by precursor directed biosynthesis. (a) Azide-tagged stambomycin analogue 37
is produced when 6-azidohexanoic acid 36 is fed to S. ambofaciens W130. (b) Acetylene-tagged stambomycin analogue 39 is produced when either
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units incorporated into the primycin complex of clinically-used
antibiotics to be identiﬁed.
These ﬁndings inspired the precursor-directed biosynthesis of
novel azide- and alkyne-containing stambomycin analogues.
Several biosynthetic engineering approaches have recently been
utilized to introduce alkyne-terminated extender units containing
5–8 carbons into erythromycin and antimycin analogues26–28.
Feeding of 8-nonynoic acid to S. ambofaciens resulted in the
production of a stambomycin analogue containing a 9-carbon
alkyne-terminated extender unit in comparable quantities to the
natural products. Thus, MccB, the AT domain from module 12 of
the stambomycin PKS and the medium chain acyl-CoA
synthetase encoded by samR0482 are useful additions to
the synthetic biology toolkit for bio-orthogonal tagging of
polyketides.
Methods
Bacterial strains and plasmids. The bacterial strains and plasmids used in the
study are described in Supplementary Table 1 and the oligonucleotide primers used
are described in Supplementary Table 2.
Construction of S. ambofaciens W130. The LAL regulatory gene, samR0484, was
PCR ampliﬁed from genomic DNA of S. ambofaciens ATCC23877 using the
primers pOSV_samR0484_FW and pOSV_samR0484_RV and cloned into the
ClaI/HindIII restriction sites of pOSV556t, placing samR0484 under the control
of the constitutive ermE* promoter. pOSV556t-samR0484 was transferred into
S. ambofaciens ATCC 23877 via conjugation from E. coli ET12567/pUZ8002
(ref. 2). One of the resulting hygromycin-resistant exconjugants was picked and
designated as S. ambofaciens W130. Subsequent analysis2, showed that S.
ambofaciens W130 overproduces the stambomycins.
Incorporation of labelled precursors into the stambomycins. MP5 agar
plates containing 5mM [U-2H]L-valine 11, [U-2H]butyric acid 12, [U-2H]L-
isoleucine 9, or [U-2H]L-leucine 10 were overlaid with sterile permeable
membranes (12–14,000Da molecular weight cut off, size 20). A 4 ml aliquot of
S. ambofaciens W130 spore stock was spread onto each plate and they were
incubated at 30 C for 4 days. The mycelia were scraped off the membranes
and extracted with methanol. The extracts were analysed by UHPLC-ESI-
TOF-MS on a Dionex 3,000 RS UHPLC attached to a Bruker MaXis mass
spectrometer (Supplementary Figs 2–5). An Agilent Zorbax Eclipse plus column
(C18, 100 2.1mm, 1.8 mm) was used. Mobile phases consisted of A (water with
0.1% formic acid) and B (acetonitrile with 0.1% formic acid), the ﬂow rate was
0.2mlmin 1 and absorbance at 240 nm was monitored. The elution proﬁle was as
follows: 0min, 20% B; 5min, 20% B; 20min, 100% B. The mass spectrometer was
operated in positive mode, with a scan range of 50–3,000m/z, and calibrated with
sodium formate (10mM) through a loop injection of 20 ml at the beginning of each
run. Source conditions were as follows. End plate offset:  500V; capillary:
 4,500V; nebulizer gas (N2): 1.4 bar; dry gas (N2): 8 l/min; dry temperature:
180 C. Ion tranfer conditions were as follows. Ion funnel 1 RF: 200 Vpp; ion
funnel 2 RF: 200 vpp; hexapole RF: 200 Vpp; quadruple ion energy: 5 ev; quad-
rupole low mass: 55m/z; collision energy: 5.0 ev; collision RF: ramped from 800 to
1,500 Vpp; transfer time: from 100 to 155ms; pre-pulse storage time: 5 ms.
Precursor directed biosynthesis of stambomycin analogue 22. Heptanoic acid
21 was fed to cultures of S. ambofaciens W130 as described above for incorporation
of labelled precursors into the stambomycins. UHPLC-ESI-Q-TOF-MS analysis of
the methanolic mycelial extracts, as described above, showed that a new metabolite
with a molecular formula corresponding to 22 was produced (Supplementary Fig. 6).
The stambomycin analogue was puriﬁed from the mycelial extract by semi-
preparative HPLC on an Agilent C18 column (100 21mm, ﬁtted with a C18
pre-column 10 21mm) connected to an Agilent 1100 instrument. The mobile
phases used were water (A) and methanol (B), both of which contained 0.1%
formic acid. The total run time was 55min with a ﬂow rate of 5ml/min and
absorbance was monitored at 240 nm. The elution conditions employed during the
run were as follows: 0min, 60% A/40% B; 5min, 60% A/40% B; 30min, 100% B;
35min, 100% B; 40min, 60% A/40% B. Fractions containing the stambomycin
analogue were identiﬁed by ESI-MS analysis, pooled and concentrated to dryness
by rotary evaporation and lyophilisation. The residue was analysed by 1H, 13C-
APT, COSY, TOCSY and HMBC NMR spectroscopy (Supplementary Table 3;
Supplementary Figs 7–11).
Synthesis of [3-2H2]heptanoic acid 23 and 8-nonynoic acid 40. General
experimental procedures. All reagents (purchased from Sigma Aldrich, Alfa Aesar,
Acros Organics or Jena Bioscience) and solvents were used as supplied, unless
otherwise stated. THF and DCM were dried over calcium hydride, distilled and
stored over 4 Å molecular sieves under argon. Dry triethylamine was obtained by
distillation over calcium hydride. Dry dimethyl malonate was obtained by vacuum
distillation at 37mbar pressure at 90 C under argon and stored over 4 Å molecular
sieves under argon. Commercially available p-toluenesulphonyl chloride was
recrystallized before use. To a solution of p-toluenesulphonyl chloride (25 g) in
chloroform (100ml) was added hexane (500ml). The resulting mixture was stirred
for 30min, the white precipitate formed was removed via ﬁltration and the solvent
was removed under vacuum. Solvents were evaporated using a Buchi Rotavapor
R-200 equipped with a Buchi Vacuubrand pump. Residual solvent was removed on
a high vacuum line using an Edwards E2M5 vacuum pump. Flash chromatography
was conducted on Fluka Silica Gel (40–63 mm, 60Å). TLC was peformed on alu-
minium backed plates pre-coated with Merck silica gel (60 F254) and visualised by
ultraviolet radiation and potassium permanganate. All glassware was dried by
heating in a 140 C oven for a minimum of 2 h.
Low resolution ESI mass spectra were recorded using a Bruker Esquire 2000
spectrometer and high resolution mass spectra were measured by the University of
Warwick Mass Spectrometry service on a Bruker MaXis ESI-Q-TOF mass
spectrometer. NMR spectra were obtained using a Bruker DPX400 (1H 400MHz
and 13C 100MHz) equipped with a proton-carbon dual probe. High ﬁeld spectra
were measured by the University of Warwick NMR Service using Bruker AV
III-600 (1H 600MHz and 13C 150MHz) or AV II-700 (1H 700MHz and 13C
175MHz) instruments. Chemical shifts are quoted in ppm with respect to the
residual solvent peak. Deuterated solvents (Sigma Aldrich) were used as supplied.
[1-2H2]n-pentanol 28. To a stirred suspension of lithium aluminium deuteride
(1.96 g, 51.7mmol, 3 equiv) in 25ml of dry THF under argon was added methyl
valerate (2.25ml, 17.2mmol, 1 equiv) in 5ml of dry THF drop wise. The resulting
mixture was heated to 70 C and the reaction was monitored by TLC (25% ethyl
acetate in 40–60 C pet. ether). Upon completion, the reaction was cooled to 0 C
and quenched with 2M HCl, resulting in a white precipitate which was removed by
vacuum ﬁltration. The ﬁltrate was concentrated in vacuo and diluted with 250ml of
water. The resulting solution was extracted with 3 100ml ethyl acetate. The
organics were combined, washed with brine and dried over magnesium sulfate. The
solvent was removed in vacuo to yield the crude product, which was puriﬁed by
ﬂash column chromatography (silica, 25% diethyl ether in pentane) to yield the
product as a colourless oil (1.37 g, 88%). 1H NMR (400MHz, CDCl3): d 1.54
(t, 2H, J¼ 6.5Hz), 1.32–1.28 (m, 4H,), 0.86 (t, 3H, J¼ 6.5Hz); 13C NMR
(100MHz, CDCl3): d 62.3 (sep, J¼ 19.7Hz), 32.4, 28.0, 22.5, 14.0.
[1-2H2]n-pentane 4-methylbenzenesulfonate 29. To a stirred solution of
[1-2H2]n-pentanol 28 (1.17 g, 12.9mmol, 1 equiv) in 23ml of dry DCM, under
argon, was added 4-dimethylamino-pyridine (473mg, 3.88mmol, 0.3 equiv) and
triethylamine (3.27 g, 32.3mmol, 2.5 equiv) followed by p-toluene sulfonyl chloride
(2.71 g, 14.4mmol, 1.1 equiv). The reaction was stirred at room temperature under
argon for 17 h, after which TLC indicated that it had gone to completion.
Ethanolamine (1.58 g, 26.6mmol, 2 equiv) was added and the resulting mixture was
stirred for a further 2 h. 125ml of water was added, the layers were separated and
the aqueous layer was extracted with 4 50ml of DCM. The organics were
combined, washed with brine and dried over magnesium sulfate. The solvent was
removed in vacuo and the residue was puriﬁed via ﬂash column chromatography
(silica, 10% ethyl acetate in 40–60 C pet ether) to give the product as a colourless
oil (2.13 g, 68%). 1H NMR (400MHz, CDCl3): d 7.79 (d, 2H, J¼ 8.0Hz), 7.34
(d, 2H, J¼ 8.0Hz), 2.44 (s, 3H), 1.62 (t, 2H, J¼ 7.0Hz), 1.28–1.23 (m, 4H), 0.84
(t, 3H, J¼ 7.0Hz); 13C NMR (100MHz, CDCl3): d 144.7, 133.3, 129.8, 127.9, 70.2
(sep, J¼ 22.7Hz), 28.3, 27.4, 22.1, 21.7, 13.8. HRMS (m/z) [MþH]þ calculated for
C12H15D2NaO3S, 267.0994; found, 267.0990.
dimethyl ([1-2H2]n-pentyl)malonate 30. To a stirred suspension of sodium
hydride (471mg, 19.7mmol, 14.8 equiv) in 10ml of dry DCM, under argon, was
added distilled dimethyl malonate (2.70 g, 20.5mmol, 5 equiv) in 15ml dry of THF
drop wise. The resulting mixture was stirred at 60 C for 1 h and [1-2H2]
n-pentyl-4-methylbenzenesulfonate 29 (1.00 g, 4.09mmol, 1 equiv) in 10ml of dry
THF was added. Stirring was continued at 60 C under argon for a further 36 h,
after which TLC indicated that the reaction had gone to completion. 125ml of
water was added cautiously and the aqueous layer was extracted with 4 100ml of
ethyl acetate. The organics were combined, washed with brine and dried over
magnesium sulfate. The solvent was removed in vacuo and the residue was puriﬁed
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Figure 7 | Structure of primycin A. The site of incorporation of the unusual
butylmalonyl-CoA extender unit, which is proposed to be assembled by a
YCC-dependent pathway, is highlighted in red.
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by ﬂash column chromatography (silica, 25% ethyl acetate in 40–60 C pet ether),
yielding the product as a colourless oil (616mg, 74%). 1H NMR (400MHz, CDCl3):
d 3.69 (s, 6H), 3.30 (s, 1H), 1.29–1.22 (6H, m), 0.84 (t, 3H, J¼ 7.5Hz); 13C NMR
(100MHz, CDCl3): d 170.0, 52.4, 51.6, 31.3, 28.2 (sep, J¼ 20.0Hz), 26.8, 22.3, 13.9;
HRMS (m/z): [MþNa]þ calculated for C10H16D2NaO4, 227.1223; found,
227.1221.
[3-2H2]n-heptanoic acid 23. To a stirred solution of dimethyl ([1-2H2]n-
pentyl)malonate 30 (500mg, 2.45mmol, 1 equiv) in 10ml of methanol, was added
5M sodium hydroxide (2.9ml, 14.7mmol, 6 equiv) drop wise. The resulting
mixture was stirred under reﬂux for 18 h, after which time TLC indicated that no
starting material remained. The mixture was cooled to room temperature, acidiﬁed
with 2M HCl and the methanol was removed in vacuo. 100ml of 20% brine was
added to the residue and the resulting solution was extracted with 3 75ml of
ethyl acetate. The organics were combined, dried over magnesium sulfate and the
solvent was removed in vacuo to yield diacid 31 as a crystalline solid. 15ml of
toluene was added and the resulting mixture was heated under reﬂux, at 125 C for
96 h. The mixture was cooled to room temperature and the toluene was removed in
vacuo to give the product (306mg, 95%). 1H NMR (600MHz, CDCl3): d 2.25
(s, 2H), 1.29–1.24 (m, 6H) 0.80 (t, 3H, J¼ 7.0Hz); 13C NMR (150MHz, CDCl3):
d 180.5, 34.1, 31.5, 28.7, 24.1 (sep, J¼ 19.7Hz), 22.6, 14.2; HRMS (m/z):
[M-H] calculated for C7H12D2O2, 131.1047; found, 131.1046. The 1H and
13C NMR spectra for labelled and unlabelled n-heptanoic acid are compared
in Supplementary Figs 12 and 13.
8-nonyn-1-ol. Sodium hydride (8.56 g, 357mmol) was added to ethylenediamine
(200ml) under argon and the resulting mixture was heated to 60 C for 60min.
3-Nonyl-1-ol (10.0 g, 71.4mmol) was added and the resulting deep blue solution
was stirred for 4 h, then cooled to 0 C and carefully quenched by addition of 2M
HCl until the blue colour disappeared. The mixture was extracted with EtOAc, and
the combined organics were dried (MgSO4) and concentrated under vacuum. The
crude product was puriﬁed on silica gel (25% EtOAc in hexanes) to give the
product (6.17 g, 61% yield) as a colourless oil.
1H NMR (700MHz, CDCl3): d 3.64 (t, 2H, J¼ 6.5Hz), 2.18 (td, 2H, J¼ 7.0,
3.0Hz), 1.96 (t, 1H, J¼ 3.0Hz), 1.57 (m, 2H), 1.53 (m, 2H), 1.44–1.31 (m, 6H).
13C NMR (175MHz, CDCl3): d 84.7, 68.1, 63.0, 32.7, 28.9, 28.7, 28.4, 25.6, 18.4;
HRMS (m/z): [MþNa]þ calculated for C9H15ONa, 163.1099; found, 163.1096.
8-nonynal. To a solution of oxalyl chloride (5.00ml, 57.2mmol) in dry DCM
(110ml), cooled to  78 C under argon, was added DMSO (7.50ml, 106mmol) in
dry DCM (25ml) drop wise. The reaction mixture was stirred for 5min, then
8-nonyn-1-ol (6.17 g, 44.0mmol) in dry DCM (50ml) was added and stirring was
continued for a further 15min. Dry triethylamine (26.8ml, 220mmol) was added
and the reaction mixture was allowed to warm to room temperature over 30min.
Water was added and the mixture was extracted with DCM. The combined
organics were washed with 2M HCl and saturated NaHCO3, dried (MgSO4),
and concentrated under vacuum. The crude product was puriﬁed on silica gel
(10% EtOAc in hexanes) to give the product (3.13 g, 51% yield) as a colourless oil.
1H NMR (300MHz, CDCl3): d 9.55 (s, 1H,), 2.42 (td, 2H, J¼ 8.0, 2.0Hz), 2.17
(td, 2H, J¼ 7.0, 3.0Hz), 1.92 (t, 1H, J¼ 3.0Hz), 1.62 (tt, 2H, J¼ 8.0, 8.0Hz),
1.57–1.28 (m, 6H); 13C NMR (175MHz, CDCl3): d 202.8, 84.5, 68.3, 43.8, 28.6,
28.4, 28.2, 21.9, 18.3; HRMS (m/z): [MþNa]þ calculated for C9H13ONa,
161.0937; found, 161.0939.
8-nonynoic acid 40. To a solution of 8-nonynal (3.13 g, 22.7mmol) in DMF
(30ml) was added Oxone (15.3 g, 24.9mmol). The resulting suspension was stirred
for 15min, then poured into water, acidiﬁed with 2M HCl and extracted with
EtOAc. The combined organics were dried (MgSO4) and concentrated under
vacuum to give the product (3.32 g, 95% yield) as a colourless oil.
1H-NMR (700MHz, CDCl3): d 2.29 (t, 2H, J¼ 7.5Hz), 2.12 (td, 2H, J¼ 7.0,
2.5Hz), 1.87 (t, 1H, J¼ 2.5Hz), 1.59 (tt, 2H, J¼ 7.0, 7.0Hz), 1.47 (tt, 2H, J¼ 7.5,
7.5Hz), 1.40–1.27 (m, 4H). 13C-NMR (CDCl3, 175MHz): d 179.6, 84.5, 68.3, 33.9,
28.5, 28.3, 28.2, 24.5, 18.3; HRMS (m/z): [MþNa]þ calculated for C9H13O2Na,
177.0886; found, 177.0884.
Incorporation of [3-2H2]n-heptanoic acid 23 into 22. [3-2H2]n-heptanoic acid
23 was fed to cultures of S. ambofaciens W130 and the mycelial extract was
prepared as described above. UHPLC-ESI-Q-TOF-MS analysis of the extract, as
described above, showed that both of the deuterium atoms had been retained in the
resulting 22 (Supplementary Fig. 14).
Incorporation of [3-2H2]n-heptanoic acid 23 into 32. The DrevR and DrevT::
samR0483 mutants (Supplementary Table 1) were grown at 28 C on MS agar
(2% (w/v) soy ﬂour, 2 % (w/v) D-mannitol, 2% (w/v) agar). Spores were used to
inoculate a 500ml cylindrical ﬂask containing 70ml of SY medium (0.1% (w/v)
yeast extract (Difco), 0.1% (w/v) NZ-amine (Wako) and 1% (w/v) starch; pH 7.0)
and the resulting pre-culture was grown for 2 days at 28 C at 150 rpm. 1ml of the
pre-culture was used to inoculate a 500ml cylindrical ﬂask containing 70ml of
production medium (RM-PM; 2% (w/v) potato dextrose (Difco), 1% (w/v) malt
extract (Difco), 1% (w/v) dried yeast (Asahi beer), 5% (w/v) tomato juice (Table
land, Maruzen Food), 0.1%(w/v) K2HPO4, 0.1% (w/v) NaCl, 0.03% (w/v)
MgSO4  7H2O, 0.01% (w/v) NaNO3, 0.005% (w/v) ZnSO4  7H2O and 0.005% (w/v)
CuSO4  5H2O; pH 6.5 before autoclaving). After 2 days growth at 28 C and
150 r.p.m., 0.3mM of [3-2H2]n-heptanoic acid 23 was added and the culture was
grown for three further days. 4ml of culture broth was extracted with an equal
volume of acetone and residual acetone was removed by evaporation. The pH was
adjusted to 4 by adding acetic acid and the culture broth was extracted twice with
an equal volume of ethyl acetate. The organic layer was concentrated in vacuo and
dissolved in 1.2ml of methanol. The resulting sample from the DrevR mutant
culture was analysed by UPLC-ESI-MS on an Applied Biosystems API 3200 con-
nected to a Waters ACQUITY UPLC and a Waters ACQUITY UPLC BEH C18
column (1.7 mm, 2.1mm internal diameter 50mm). The conditions were as
follows: ﬂow rate 0.7mlmin 1; solvent A, water containing 0.05% formic acid; and
solvent B, acetonitrile. After injection of 1 ml of the sample into a column that was
equilibrated with 30% solvent B, the column was developed with a linear gradient
from 30% to 100% solvent B in 1.9min and kept at 100% solvent B for 0.96min.
Mass spectra were recorded in negative ion mode.
To separate reveromycin D 32 from other reveromycin derivatives, the ethyl
acetate extracts from the DrevR and DrevT::samR0483 mutants were applied to a
PEGASIL ODS column (5mm, 4.6 250mm). The HPLC conditions were as
follows: ﬂow rate, 1mlmin 1; solvent A, water containing 0.05% formic acid; and
solvent B, MeOH, isocratic system of 78% MeOH. The fraction containing
reveromycin D 32 from the DrevT::samR0483 mutant cultures with and without
supplementation of (3-2H2)-heptanoic acid 23 was concentrated and analysed
by UPLC-ESI-MS on an Applied Biosystems API 3200 connected to a Waters
ACQUITY UPLC and a Waters ACQUITY UPLC BEH C18 column (1.7mm,
2.1 50mm). The ﬂow rate was 0.2mlmin 1 and the column was eluted
with isocratic 50% water containing 0.05% formic acid and 50% acetonitrile.
Mass spectra were recorded in negative ion mode (Supplementary Fig. 16).
Partially puriﬁed reveromycin D 32 from the DrevR mutant cultures with and
without supplementation of [3-2H2]-heptanoic acid 23 was further analysed by
negative ion ESI-TOF-MS on a Waters Synapt G2 mass spectrometer
(Supplementary Fig. 15).
Expression of samR0483 in Streptomyces sp. SN-593 DrevT. The samR0483
gene was ampliﬁed by PCR from genomic DNA of S. ambofaciens ATCC 23877
using the primers pOSV_samR0483_FW and pOSV_samR0483_RV and cloned
into the ClaI/HindIII restriction sites of pOSV556t. The resulting plasmid,
pOSV556t-samR0483, was used as the template for PCR ampliﬁcation of samR0483
using the primers 0483_BamHI and 0483_HindIII. The amplimer was cloned into
the BamHI and HindIII sites of pTYM19-Paph yielding pTYM19-Paph-samR0483,
which was used to transform E. coli GM2929 hsdS::Tn10 (pUB307::Tn7).
pTYM19-Paph-samR0483 was transferred by intergenic conjugation from
E. coli GM2929 hsdS::Tn10 (pUB307::Tn7) to Streptomyces sp. SN-593 (ref. 29).
Cloning of samR0483 into E. coli expression vectors. The MccB-encoding gene,
samR0483, was ampliﬁed by PCR from genomic DNA of S. ambofaciens ATCC
23877 using the primers TOPO_483_FW and TOPO_483_RV, and cloned into
pET151 (Invitrogen) following the manufacturer’s instructions to give pET151-
samR0483. It was then ampliﬁed from pET151-samR0483 using the primers
pET28a-samR0483_FW and pET28a-samR0483_RV and the resulting amplimer
was cloned into the NheI and NotI sites of pET28a (Novagen) to produce pET28a-
samR0483 encoding an N-terminal hexahistidine MccB fusion protein.
Overproduction and puriﬁcation of MccB. E. coli BL21(DE3) cells containing
pET28a-samR0483 were grown in 4 1L of LB medium supplemented with
kanamycin (50 mgml 1) to A600¼ 0.6–0.8 at 37 C and 180 r.p.m. Cultures were
induced by the addition of 0.7mM IPTG and incubated for 16 h at 19 C and
180 r.p.m. Cells were harvested by centrifugation at 5,500 RCF for 10min,
re-suspended in lysis buffer (50mM Tris–HCl pH 8.0, 300mM NaCl, 20mM
imidazole and 10% glycerol), sonicated and the cell debris was removed by
centrifugation (21,000 RCF for 70min). The clariﬁed cell lysate was batch bound to
5ml of Ni-IMAC resin (Bio-Rad Laboratories) for 1 h at 4 C. The resulting slurry
was transferred to a gravity-ﬂow column and washed twice with 50ml of lysis
buffer. His6-MccB was eluted with 5ml fractions containing 40, 100, 150, 250 and
450mM imidazole in lysis buffer. Protein purity was assessed by SDS–
polyacrylamide gel electrophoresis (SDS–PAGE). Fractions containing the highest
purity (Z90%) were collected and dialyzed overnight at 4 C against 50mM
Tris–HCl pH 8.0, 50mM NaCl, 10% glycerol and 1mM DTT. Dialyzed protein was
concentrated to 5–10mgml 1 using a 30,000Da molecular weight cutoff
centrifugal ﬁlter (Millipore) and injected onto a Superdex 200 column
(GE Healthcare) pre-equilibrated with 50mM Tris pH 8.0 and 1mM DTT.
Fractions were collected, analysed by SDS–PAGE for purity, concentrated to
9mgml 1 and ﬂash frozen for storage at  80 C.
For co-crystal studies, native His6-MccB was treated with TEV protease
(10U per mg of MCC) post nickel afﬁnity chromatography and dialyzed into
50mM Tris HCl pH 8.0, 50mM NaCl, 10% glycerol, 1mM DTT, and 1mM
EDTA at 18 C for 18 h. Complete digestion was veriﬁed using MALDI-TOF mass
spectrometry. The cleaved protein was dialyzed into crystallization buffer (50mM
Tris pH 8.0 and 1mM DTT) and subjected to anion exchange chromatography
(High Trap Q, GE Healthcare) to remove excess TEV protease. Cleaved MccB was
eluted using a linear gradient of 0–1M NaCl and was dialyzed into 50mM Tris pH
8.0 and 1mM DTT for co-crystallization screens.
Selenomethionine (SeMet)-derivatized His6-MccB was produced in E. coli
BL21(DE3) cells harbouring pET28a-samR0483. Cells were grown in 4 1 l of LB
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medium supplemented with kanamycin (50mgml 1) at 37 C and 180 rpm until
A600 reached 0.6. Before induction, the cells were harvested by centrifugation at
5,500 RCF for 10min, re-suspended and washed three times with 100ml of M9
medium then transferred to 4 1 l ﬂasks containing M9 medium with the
following additives: kanamycin (50mgml 1); lysine, phenylalanine, threonine
(100mg L 1); isoleucine, leucine, valine (50mg L 1); and L-SeMet
(80mg L 1)(Sigma). The temperature was then lowered to 19 C and protein
expression was induced upon the addition of 0.7mM IPTG. The SeMet substituted
protein was puriﬁed following the same procedure as native His6-MccB.
Selenomethionine incorporation was conﬁrmed using MALDI-TOF mass
spectrometry.
Crystallization of apo- and hexanoyl-CoA-bound forms of MccB. Apo-MccB
crystallization. Frozen SeMET aliquots of His6-MccB were thawed on ice and
incubated with 5mM biotin and 5mM heptanoic acid (50mM stocks in 0.1M
Hepes pH 7.2 and 100% DMSO, respectively) (Sigma-Aldrich) at 4 C for 1 h
before crystallization screens. Small crystals of apo-MccB formed overnight in 30%
methyl propanediol (MPD) (Qiagen), 0.2M magnesium acetate and 0.1M MES pH
6.5. Diffraction-quality crystals were obtained by mixing 2 ml of protein solution
with 2 ml of well solution (5–11% MPD, 0.2M magnesium acetate and 0.1M MES
pH 6.5–6.8) using the hanging drop vapour diffusion method. Apo-MccB crystals
were further optimized via four consecutive rounds of seeding using a Seed Bead
(Hampton Research). The crystals were harvested, cryo-protected with 25%
ethylene glycol and ﬂash frozen in liquid nitrogen for subsequent X-ray diffraction
data collection.
MccB Hexanoyl-CoA co-crystallization. Before crystallization, cleaved native
MccB at 7mgml 1 was incubated with 5mM biotin and either 5mM or 10mM
hexanoyl-CoA (50mM stock in 0.1M Hepes pH 7.2) (Sigma-Aldrich). Crystals of
the MccB-hexanoyl-CoA complex were obtained by mixing 2 ml of protein solution
with 2 ml of mother liquor (26–32% PEG 5,000 MME, 0.2M ammonium sulfate
and 0.1 MES pH 6.5–7.0) using the hanging drop vapour diffusion method. MccB
co-crystals grew at 25 C over a period of 5 days. MccB co-crystals were
cryo-protected in well solution plus 25% glycerol and ﬂash frozen in liquid
nitrogen for subsequent X-ray diffraction data collection.
Collection and analysis of X-ray diffraction data. Data were collected at the
Advanced Light Source (ALS), Lawrence Berkeley National Laboratory, using
beamlines 8.2.1 or 8.2.2. Data sets corresponding to the apo and mono-hexanoyl-
CoA co-crystal forms of MccB were indexed, integrated, and scaled using Mosﬂm
or HKL2000, respectively30,31. Two separate data sets from a single crystal were
collected for the tetra-hexanoyl-CoA MccB co-crystal form with 1 and 2 s exposure
times. The individual data sets were processed using Mosﬂim and scaled together
using Aimless32. Phasing of apo-MccB was accomplished via molecular
replacement (Phaser33) using the hexameric apo-PccB D422A structure (PDB ID:
3IBB) as a search model. An initial model was built using Autobuild, and this
model was further improved through iterative rounds of model building (COOT
(ref. 34)) and reﬁnement (PHENIX.REFINE35). For the co-crystal structures,
electron density corresponding to hexanoyl-CoA was identiﬁed using PHENIX
LigandFit and ligand restraints were generated using PHENIX eLBOW. Both the
apo and co-crystal structures were validated using PHENIX.VALIDATE and
PDB_REDO36,37. Resolution cutoffs were made based on a combination
I/sigma, CC1/2, and per cent completeness values37. Crystallographic statistics for
the three MccB crystal forms are listed in Supplementary Table 4 and the 2F0-FC
SA omit maps for these structures and for the bound hexanoyl-CoA are shown in
Supplementary Figs 19 and 26–28.
Precursor directed biosynthesis of 37 and 39. 6-azidohexanoic acid 36,
6-heptynoic acid 38 and 8-nonynoic acid 40 were fed to cultures of S. ambofaciens
W130 as described for precursor directed biosynthesis of stambomycin analogue
22. UHPLC-ESI-QTOF-MS analysis of the methanolic mycelial extracts, as
described for precursor directed biosynthesis of stambomycin analogue 22, showed
that new metabolites with molecular formulae corresponding to stambomycin
analogues 37 (Supplementary Fig. 21) and 39 (Supplementary Figs 22 and 23) were
produced.
Stambomycin analogue 39 was puriﬁed from the mycelial extract as described
for stambomycin analogue 22 and analysed by 1H NMR spectroscopy
(Supplementary Fig. 24).
Reaction of 39 with azide-PEG3-biotin conjugate. To stambomycin analogue 39
(4.5mg, 3.28 mmoles) suspended in degassed methanol (600 ml) and butanol
(400 ml) under argon was added copper sulfate (0.1mg, 0.65 mmoles, 0.2 equiv) and
sodium ascorbate (0.65mg, 3.28 mmoles, 1 equiv) in degassed water (1ml), followed
by azide-PEG3-conjugate (1.46mg, 3.28 mmoles, 1 equiv) in degassed butanol
(200 ml). Following 64 h stirring at 21 C, the solvent was removed in vacuo and the
biotinylated stambomycin derivative was puriﬁed by semi-preparative HPLC on an
Agilent C18 column (100 21mm, ﬁtted with a C18 pre-column 10 21mm).
Elution conditions were as follows: ﬂow rate, 5mlmin 1; solvent A, water
containing 0.1% formic acid; solvent B, methanol containing 0.1% formic acid;
gradient initiated after 5min from 40% B to 100% B over 25min. The biotinylated
stambomycin derivative eluted between 18.6 and 19.2min. 2mg (34%) of the
biotinylated stambomycin derivative was recovered and analysed by HRMS
(m/z calculated for C91H162N7NaO27Sþ : 621.0339 [MþHþ 2Na]3þ ; Found:
621.0337) and 1H NMR spectroscopy (Supplementary Fig. 25).
Data availability. X-ray crystallographic data have been deposited in the PDB
under the accession codes 5INI, 5INF and 5ING. All other data are included in the
manuscript (as ﬁgure source data or Supplementary Information) or are available
from the authors on request.
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